Catalyst Capital Advisors’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-450
Closed -$7K 496
2019
Q2
$7K Buy
+450
New +$7K ﹤0.01% 357